Roche Doubles Down on Jnana's RAPID Platform in $2B Deal (Updated)

It's been a lucrative Tuesday for Jnana Therapeutics which forged a second small molecule discovery and development collaboration and licensing agreement with Roche valued at up to $2 billion.